Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Sherman

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Nuclear Medicine and Biology|October 2, 2001
The role of species-dependent metabolism in the regional brain retention of 18F-labeled muscarinic acetylcholine receptor ligandsM B Skaddan, P S Sherman, M R Kilbourn
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
In vivo binding of the dopamine uptake inhibitor [18F]GBR 13119 in MPTP-treated C57BL/6 miceM R Kilbourn, G K Mulholland, P S Sherman, et al.
Nuclear Medicine and Biology|August 12, 2000
Synthesis and in vivo evaluation of (E)-N-[(11)C]Methyl-4- (3-pyridinyl)-3-butene-1-amine ([(11)C]metanicotine) as a nicotinic receptor radioligandC Brown-Proctor, S E Snyder, P S Sherman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1997
Simplifying the dosimetry of carbon-11-labeled radiopharmaceuticalsM C Wrobel, J E Carey, P S Sherman, et al.
Synapse (New York, N.Y.)|February 1, 1996
In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP)M R Kilbourn, S E Snyder, P S Sherman, et al.
Nuclear Medicine and Biology|May 1, 1996
Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transportersM R Kilbourn, K A Frey, T Vander Borght, et al.
Nuclear Medicine and Biology|March 30, 1999
Synthesis and evaluation of 6-[11C]methoxy-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-1,2- benzisoxazole as an in vivo radioligand for acetylcholinesteraseC Brown-Proctor, S E Snyder, P S Sherman, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 15, 2001
Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptorsM B Skaddan, M R Kilbourn, S E Snyder, et al.
Diabetes|March 17, 1999
Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetesH Schmid, L A Forman, X Cao, et al.
European Journal of Pharmacology|July 18, 1989
Regional brain distribution of [18F]GBR 13119, a dopamine uptake inhibitor, in CD-1 and C57BL/6 miceM R Kilbourn, M S Haka, G K Mulholland, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Nuclear Medicine and Biology|October 2, 2001
The role of species-dependent metabolism in the regional brain retention of 18F-labeled muscarinic acetylcholine receptor ligandsM B Skaddan, P S Sherman, M R Kilbourn
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
In vivo binding of the dopamine uptake inhibitor [18F]GBR 13119 in MPTP-treated C57BL/6 miceM R Kilbourn, G K Mulholland, P S Sherman, et al.
Nuclear Medicine and Biology|August 12, 2000
Synthesis and in vivo evaluation of (E)-N-[(11)C]Methyl-4- (3-pyridinyl)-3-butene-1-amine ([(11)C]metanicotine) as a nicotinic receptor radioligandC Brown-Proctor, S E Snyder, P S Sherman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1997
Simplifying the dosimetry of carbon-11-labeled radiopharmaceuticalsM C Wrobel, J E Carey, P S Sherman, et al.
Synapse (New York, N.Y.)|February 1, 1996
In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP)M R Kilbourn, S E Snyder, P S Sherman, et al.
Nuclear Medicine and Biology|May 1, 1996
Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transportersM R Kilbourn, K A Frey, T Vander Borght, et al.
Nuclear Medicine and Biology|March 30, 1999
Synthesis and evaluation of 6-[11C]methoxy-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-1,2- benzisoxazole as an in vivo radioligand for acetylcholinesteraseC Brown-Proctor, S E Snyder, P S Sherman, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 15, 2001
Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptorsM B Skaddan, M R Kilbourn, S E Snyder, et al.
Diabetes|March 17, 1999
Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetesH Schmid, L A Forman, X Cao, et al.
European Journal of Pharmacology|July 18, 1989
Regional brain distribution of [18F]GBR 13119, a dopamine uptake inhibitor, in CD-1 and C57BL/6 miceM R Kilbourn, M S Haka, G K Mulholland, et al.
Pageof 4